Rebecca Bakker‐Arkema

Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin

Alan S. Brown, Rebecca Bakker‐Arkema, Laurence G. Yellen et al. · Journal of the American College of Cardiology · 1998 · 185 citations

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +10

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner

Juan Pedro‐Botet, Ernst J. Schaefer, Rebecca Bakker‐Arkema et al. · Atherosclerosis · 2001 · 170 citations

Life Sciences, Biochemistry, Genetics +13

An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor

Donald M. Black, Rebecca Bakker‐Arkema, J.W. Nawrocki · Archives of Internal Medicine · 1998 · 163 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement

Robert D. Shamburek, Rebecca Bakker‐Arkema, Bruce J. Auerbach et al. · Journal of clinical lipidology · 2015 · 95 citations · Full text

Life Sciences, Biochemistry, Genetics +17

Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study

Robert D. Shamburek, Rebecca Bakker‐Arkema, Alexandra M. Shamburek et al. · Circulation Research · 2015 · 82 citations

Life Sciences, Pharmacokinetics, Pharmacology +17